These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 25441426)
21. Targeting p73--a potential approach in cancer treatment. Slade N; Horvat A Curr Pharm Des; 2011; 17(6):591-602. PubMed ID: 21391909 [TBL] [Abstract][Full Text] [Related]
22. Wild-type p53 and p73 negatively regulate expression of proliferation related genes. Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488 [TBL] [Abstract][Full Text] [Related]
23. p63 and p73: roles in development and tumor formation. Moll UM; Slade N Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445 [TBL] [Abstract][Full Text] [Related]
24. Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2. Taebunpakul P; Sayan BS; Flinterman M; Klanrit P; Gäken J; Odell EW; Melino G; Tavassoli M Apoptosis; 2012 Aug; 17(8):762-76. PubMed ID: 22484480 [TBL] [Abstract][Full Text] [Related]
25. Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. Fillippovich I; Sorokina N; Gatei M; Haupt Y; Hobson K; Moallem E; Spring K; Mould M; McGuckin MA; Lavin MF; Khanna KK Oncogene; 2001 Jan; 20(4):514-22. PubMed ID: 11313982 [TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of p73 and p53 regulation and effector functions. Fang L; Lee SW; Aaronson SA J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283 [TBL] [Abstract][Full Text] [Related]
27. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax. Patel S; George R; Autore F; Fraternali F; Ladbury JE; Nikolova PV Nucleic Acids Res; 2008 Sep; 36(16):5139-51. PubMed ID: 18676979 [TBL] [Abstract][Full Text] [Related]
28. Role of p73 in malignancy: tumor suppressor or oncogene? Stiewe T; Pützer BM Cell Death Differ; 2002 Mar; 9(3):237-45. PubMed ID: 11859406 [TBL] [Abstract][Full Text] [Related]
29. [The structure and cellular regulation of p73: their implication in anticancer therapy]. Zawacka-Pankau J; Maleńczyk K; Sznarkowska A Postepy Hig Med Dosw (Online); 2010 Feb; 64():78-86. PubMed ID: 20231765 [TBL] [Abstract][Full Text] [Related]
30. The cell type-specific effect of TAp73 isoforms on the cell cycle and apoptosis. Holcakova J; Ceskova P; Hrstka R; Muller P; Dubska L; Coates PJ; Palecek E; Vojtesek B Cell Mol Biol Lett; 2008; 13(3):404-20. PubMed ID: 18350258 [TBL] [Abstract][Full Text] [Related]
31. C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity. Sauer M; Bretz AC; Beinoraviciute-Kellner R; Beitzinger M; Burek C; Rosenwald A; Harms GS; Stiewe T Nucleic Acids Res; 2008 Apr; 36(6):1900-12. PubMed ID: 18267967 [TBL] [Abstract][Full Text] [Related]
32. The functional domains in p53 family proteins exhibit both common and distinct properties. Harms KL; Chen X Cell Death Differ; 2006 Jun; 13(6):890-7. PubMed ID: 16543939 [No Abstract] [Full Text] [Related]
33. The role of the TP73 gene and its transcripts in neuro-oncology. Jancalek R Br J Neurosurg; 2014 Oct; 28(5):598-605. PubMed ID: 24742294 [TBL] [Abstract][Full Text] [Related]
34. Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73. Zdzalik M; Pustelny K; Kedracka-Krok S; Huben K; Pecak A; Wladyka B; Jankowski S; Dubin A; Potempa J; Dubin G Cell Cycle; 2010 Nov; 9(22):4584-91. PubMed ID: 21088494 [TBL] [Abstract][Full Text] [Related]
35. Conformational stability and activity of p73 require a second helix in the tetramerization domain. Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140 [TBL] [Abstract][Full Text] [Related]
36. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549. He Y; Fan SZ; Jiang YG Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670 [TBL] [Abstract][Full Text] [Related]
37. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Tomasini R; Seux M; Nowak J; Bontemps C; Carrier A; Dagorn JC; Pébusque MJ; Iovanna JL; Dusetti NJ Oncogene; 2005 Dec; 24(55):8093-104. PubMed ID: 16044147 [TBL] [Abstract][Full Text] [Related]
38. p73 and p63 sustain cellular growth by transcriptional activation of cell cycle progression genes. Lefkimmiatis K; Caratozzolo MF; Merlo P; D'Erchia AM; Navarro B; Levrero M; Sbisa' E; Tullo A Cancer Res; 2009 Nov; 69(22):8563-71. PubMed ID: 19861536 [TBL] [Abstract][Full Text] [Related]
39. Regulation of p73 activity by post-translational modifications. Conforti F; Sayan AE; Sreekumar R; Sayan BS Cell Death Dis; 2012 Mar; 3(3):e285. PubMed ID: 22419114 [TBL] [Abstract][Full Text] [Related]
40. Induction of apoptosis by the p53-related p73 and partial inhibition by the baculovirus-encoded p35 in neuronal cells. Lo WD; Akhmametyeva EM; Zhu L; Friesen PD; Chang LS Brain Res Mol Brain Res; 2003 May; 113(1-2):1-12. PubMed ID: 12750001 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]